Advertisement
UK markets close in 4 hours 41 minutes
  • FTSE 100

    7,507.94
    -7.44 (-0.10%)
     
  • FTSE 250

    18,596.69
    -70.04 (-0.38%)
     
  • AIM

    720.05
    +1.93 (+0.27%)
     
  • GBP/EUR

    1.1676
    +0.0016 (+0.13%)
     
  • GBP/USD

    1.2581
    +0.0020 (+0.16%)
     
  • Bitcoin GBP

    34,318.47
    -345.94 (-1.00%)
     
  • CMC Crypto 200

    880.92
    +638.24 (+263.00%)
     
  • S&P 500

    4,549.34
    -17.84 (-0.39%)
     
  • DOW

    36,054.43
    -70.17 (-0.19%)
     
  • CRUDE OIL

    69.91
    +0.53 (+0.76%)
     
  • GOLD FUTURES

    2,048.20
    +0.30 (+0.01%)
     
  • NIKKEI 225

    32,858.31
    -587.59 (-1.76%)
     
  • HANG SENG

    16,345.89
    -117.37 (-0.71%)
     
  • DAX

    16,627.24
    -29.20 (-0.18%)
     
  • CAC 40

    7,431.49
    -4.50 (-0.06%)
     

Why CureVac's Shares Jumped on Tuesday

Why CureVac's Shares Jumped on Tuesday

Shares of CureVac (NASDAQ: CVAC) rose as much as 19.1% on Tuesday. Despite the rise, CureVac is down more than 59% over the past year, though it is now up more than 61% over the past three months. Investors continued to flock to the healthcare stock after the biotech announced late Friday that several of its messenger RNA vaccines were doing well in early trials.